๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Deficiency of a cholinergic differentiating factor in fibroblasts of patients with Alzheimer's disease

โœ Scribed by Dr. John A. Kessler


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
438 KB
Volume
21
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Measuring cognitive change in a cohort o
โœ Douglas R. Galasko; Robert L. Gould; Ian S. Abramson; David P. Salmon ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 133 KB ๐Ÿ‘ 2 views

Annualized rates of cognitive change in Alzheimer's disease (AD), an important index of disease progression, show marked variability. To determine factors leading to such variability, we computed rates of change in a cohort of patients with AD tested annually with the Mini Mental State Examination (

Psychometric behaviour of BDI in Alzheim
โœ A. C. Wagle; L. W. Ho; S. A. Wagle; G. E. Berrios ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

The psychometric properties of the Beck Depression Inventory (BDI) in subjects with Alzheimer's disease (AD) and depression have not been fully evaluated. Item endorsement patterns may be distorted by the presence of AD. This was tested by applying the BDI to a sample of 129 subjects with probable A

DNA cytosine methylation in brain of pat
โœ Netanel G. Schwob; Josephine Nalbantoglu; Kenneth E. M. Hastings; Tom Mikkelsen; ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 399 KB ๐Ÿ‘ 2 views

## Abstract We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in pe